# Illumina, Inc.: Form 10-Q for the period ended Jun 29, 2025

- Company: [Illumina, Inc.](/companies/ilmn.md) (CIK 1110803)
- Form: 10-Q
- Filed: 2025-08-01
- Accepted by EDGAR: Aug 1, 2025, 17:24 ET
- Period: 2025-06-29
- Accession: 0001110803-25-000060
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1110803/000111080325000060/ilmn-20250629.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1110803/000111080325000060/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-06-29.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2025-03-31 to 2025-06-29 | $1.06bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months, 2024-12-30 to 2025-06-29 | $2.10bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2025-03-31 to 2025-06-29 | $364.0m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months, 2024-12-30 to 2025-06-29 | $722.0m | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2025-03-31 to 2025-06-29 | $695.0m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2024-12-30 to 2025-06-29 | $1.38bn | us-gaap:GrossProfit |
| Research and development | 3 months, 2025-03-31 to 2025-06-29 | $247.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2024-12-30 to 2025-06-29 | $499.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2025-03-31 to 2025-06-29 | $234.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2024-12-30 to 2025-06-29 | $501.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2025-03-31 to 2025-06-29 | $214.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2024-12-30 to 2025-06-29 | $378.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2025-03-31 to 2025-06-29 | $25.0m | us-gaap:InterestExpenseNonoperating |
| Interest expense | 6 months, 2024-12-30 to 2025-06-29 | $50.0m | us-gaap:InterestExpenseNonoperating |
| Income tax | 3 months, 2025-03-31 to 2025-06-29 | $71.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2024-12-30 to 2025-06-29 | $122.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2025-03-31 to 2025-06-29 | $235.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2024-12-30 to 2025-06-29 | $366.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2025-03-31 to 2025-06-29 | $1.49 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2024-12-30 to 2025-06-29 | $2.31 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2025-03-31 to 2025-06-29 | $1.49 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2024-12-30 to 2025-06-29 | $2.32 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2025-03-31 to 2025-06-29 | 157,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2024-12-30 to 2025-06-29 | 158,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2024-12-30 to 2025-06-29 | $474.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2024-12-30 to 2025-06-29 | $62.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months, 2024-12-30 to 2025-06-29 | $570.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | at 2025-06-29 | $2.64bn | us-gaap:AssetsCurrent |
| Total assets | at 2025-06-29 | $6.09bn | us-gaap:Assets |
| Current liabilities | at 2025-06-29 | $1.46bn | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | at 2025-06-29 | $2.26bn | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1110803/000111080325000060/ilmn-20250629.htm

Filed Aug 1, 2025.
Source: SEC EDGAR, the filing index for accession 0001110803-25-000060. Last ingested by Listed: Nov 14, 2026, 13:59 ET. No prices; not investment advice.
